Mutual of America Capital Management LLC Has $6.78 Million Holdings in CVS Health Co. (NYSE:CVS)

Mutual of America Capital Management LLC cut its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 151,084 shares of the pharmacy operator's stock after selling 4,170 shares during the quarter. Mutual of America Capital Management LLC's holdings in CVS Health were worth $6,782,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Generali Investments Towarzystwo Funduszy Inwestycyjnych grew its position in shares of CVS Health by 8.1% in the 4th quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych now owns 4,000 shares of the pharmacy operator's stock valued at $180,000 after purchasing an additional 300 shares during the period. Versor Investments LP grew its position in shares of CVS Health by 55.9% in the 4th quarter. Versor Investments LP now owns 9,200 shares of the pharmacy operator's stock valued at $413,000 after purchasing an additional 3,300 shares during the period. Proficio Capital Partners LLC acquired a new position in shares of CVS Health in the 4th quarter valued at approximately $5,544,000. Oppenheimer & Co. Inc. grew its position in shares of CVS Health by 3.5% in the 4th quarter. Oppenheimer & Co. Inc. now owns 103,378 shares of the pharmacy operator's stock valued at $4,641,000 after purchasing an additional 3,530 shares during the period. Finally, Kovack Advisors Inc. grew its position in shares of CVS Health by 23.4% in the 4th quarter. Kovack Advisors Inc. now owns 10,940 shares of the pharmacy operator's stock valued at $491,000 after purchasing an additional 2,078 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company's stock, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.24% of the stock is owned by corporate insiders.

CVS Health Price Performance

Shares of CVS stock traded down $0.90 on Monday, hitting $64.82. 7,077,932 shares of the company's stock were exchanged, compared to its average volume of 12,413,927. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock has a market cap of $81.72 billion, a P/E ratio of 17.71, a price-to-earnings-growth ratio of 0.98 and a beta of 0.61. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a 50 day moving average of $54.33 and a 200 day moving average of $56.47.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities research analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.10%. CVS Health's dividend payout ratio is presently 72.68%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Edward Jones upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Thursday, January 30th. Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. JPMorgan Chase & Co. upped their price objective on CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 18th. Finally, UBS Group dropped their price objective on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 11th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and a consensus target price of $69.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.